Cyberknife Treatment for Low and Intermediate Risk Prostate Cancer-Reference-Cited by-同舟云学术

Cyberknife Treatment for Low and Intermediate Risk Prostate Cancer

Published:2015-04 Issue:5 Volume:33 Page:188-192
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Detti B.,Bonomo P.,Masi L.,Doro R.,Cipressi S.,Iermano C.,Bonucci I.,Franceschini D.,Di Cataldo V.,Di Brina L.,Baki M.,Simontacchi G.,Meattini I.,Carini M.,Serni S.,Nicita G.,Livi L.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357907.2015.1019679

Reference20 articles.

1. Cancer statistics, 2013

2. How low is the α/β ratio for prostate cancer?

3. Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue

4. Confirmation of a Low α/β Ratio for Prostate Cancer Treated by External Beam Radiation Therapy Alone Using a Post-Treatment Repeated-Measures Model for PSA Dynamics

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexual Function in Patients Treated With Stereotactic Radiotherapy For Prostate Cancer: A Systematic Review of the Current Evidence;The Journal of Sexual Medicine;2019-09

2. Prosztatarákban szenvedő betegek definitív ellátásának tanulságai és modern stratégiái;Orvosi Hetilap;2018-08

3. Dosimetric impact of intra-fraction prostate motion under a tumour-tracking system in hypofractionated robotic radiosurgery;PLOS ONE;2018-04-05

4. Advances in Radiotherapy for Prostate Cancer Treatment;Molecular & Diagnostic Imaging in Prostate Cancer;2018

5. Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost–Utility Analysis;Clinical Oncology;2017-11